More news about Clinerion
Company profiles on Clinerion

Clinerion announces a new technology for clinical trial patient recruitment

16.08.2017 15:17

Related tags


Clinerion’s new technology uses exclusively anonymized records, but enables the duly authorized clinical trial manager at the hospital to re-identify eligible patients. The “anonymized identification” (ANID) technology involves exclusively the use of anonymized data, ensuring the privacy and security of patient information.

Clinerion's Patient Recruitment System (PRS) accelerates clinical research by radically improving the efficiency and effectiveness of trial recruitment. The new “anonymized identification” (ANID) technology, implemented in PRS, significantly reduces any risk of private information being revealed when using patient medical records to evaluate study feasibility, or identifying patients for enrollment in clinical trials.

The new technology uses exclusively anonymized records, but enables the duly authorized clinical trial manager at the hospital to re-identify eligible patients. Although all identifiable personal information and patient record identifiers have been completely stripped from medical records before use, the new technology can enable a healthcare provider to match anonymized records with corresponding hospital records through the use of a combination of techniques, incl. checksum algorithms.

The new system set-up involves a one-way, outbound-only connection between the hospital IT infrastructure and the locally hosted Clinerion PRS server, further increasing information security.

While offering a new, enhanced level of data protection, “anonymized identification” (ANID) maintains all the advantages of the legacy Clinerion PRS technology, such as following HIPAA rules regarding protection against accidental identification. Query results for feasibility requests are stored in the PRS secure private cloud environment, which only sees aggregated counts of the patients which fit the queries. The performance of PRS is not affected, results still appear in real-time and the number of eligible patients found remains 10-30 higher than through conventional methods.

“This truly disruptive approach has a number of advantages over conventional methods, making data research and patient identification considerably more secure,” says Andreas Walter, Chief Technology Officer of Clinerion. “Anonymization is the gold standard when it comes to patient privacy protection during the use of patient medical data. “Anonymized identification” (ANID) removes all possible sources of concerns.”

 “The privacy of the individual patient is paramount and patient data security is increasingly legislated,” says Ulf Claesson, Chief Executive Officer of Clinerion. “We are pleased to offer a solution which changes the game. At the same time, this revolutionary technology future-proofs Clinerion’s services for clinical trial patient recruitment and market access activities.”

All new PRS installations will use the new technology from now on. Existing installations will be migrated at the request of partner hospitals. “Anonymized identification” (ANID) can be expanded for any uses wherein a database of anonymized records must be queried and the records later re-identified.

(Press release)

Please login or
register to comment

Please login or sign up to comment. Commenting guidelines


A showcase for female CEOs

Startupticker has recorded Swiss start-ups with female CEOs and ranked them by sector. The map which includes links to 80+ companies can be downloaded in our article.




By continuing to use this website you agree with our TERMS AND CONDITIONS